Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Evommune Inc. (EVMN) had Return on Equity of -12.28% for the most recently reported fiscal quarter, ending 2026-09-30.
| Income Statement Financials | |
-- |
|
$-30.88M |
|
-- |
|
-- |
|
$33.33M |
|
$-33.33M |
|
$2.45M |
|
$-30.88M |
|
$-30.88M |
|
$-30.88M |
|
$-30.88M |
|
$-30.88M |
|
$-30.88M |
|
$-33.33M |
|
$-33.05M |
|
36.33M |
|
36.33M |
|
$-0.85 |
|
$-0.85 |
|
| Balance Sheet Financials | |
$174.56M |
|
$1.63M |
|
$103.74M |
|
$278.30M |
|
$20.48M |
|
$0.34M |
|
$6.45M |
|
$26.93M |
|
$251.37M |
|
$251.37M |
|
$251.37M |
|
36.38M |
|
| Cash Flow Statement Financials | |
$-73.70M |
|
$-40.74M |
|
$117.74M |
|
$45.48M |
|
$48.77M |
|
$3.29M |
|
$12.48M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.52 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-74.20M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-12.28% |
-12.28% |
|
-11.09% |
|
-12.27% |
|
$6.91 |
|
$-2.04 |
|
$-2.03 |
|